Back to Emmenia

    Methodology & evidence

    Last updated:

    Emmenia is built as a closed-loop menstrual pain OS: predict hard days, run phase-timed protocols with inspectable evidence grades, measure what worked for you, and export a clinician-ready summary. This page explains how those claims are grounded — and where we stop short of medical-device or diagnostic language.

    What this is (and is not)

    • Emmenia is a wellness tracking and education product, not a medical device and not a substitute for clinical care.
    • Evidence grades summarise published research in plain language. They are not prescriptions and do not personalise dosing for you.
    • Condition pathways (endo red flags, heavy bleeding, PMDD diary) are conversation starters for clinicians — not diagnoses.

    Ritual evidence grades (A / B / C)

    Each ritual card that maps to a care remedy carries a grade. Grades are assigned from the published literature for menstrual pain or closely related outcomes — not from marketing claims or invented citation IDs.

    • Grade A — stronger trial support
      Multiple randomised trials or meta-analyses for menstrual pain or closely related outcomes.
    • Grade B — some clinical support
      Some clinical trials or consistent observational support — useful, with more protocol variation.
    • Grade C — emerging / traditional
      Traditional use, small studies, or a strong mechanistic rationale with limited menstrual-specific trials.

    Current graded rituals

    The table below mirrors what signed-in users see on ritual cards (summary, typical use, cautions, and source notes). Source notes describe study types; we do not fabricate PMIDs.

    Heat pad

    Grade A — stronger trial support

    Continuous low-level heat is comparable to NSAIDs for primary dysmenorrhea in randomised trials and reviews — often easing pain within the first hour when started early.

    Typical use
    15–20 minutes of warm (not hot) heat over the lower abdomen or back; repeat with skin rests. Many protocols start 60–90 minutes before usual peak pain.
    Cautions
    • Avoid high heat or prolonged contact that risks burns
    • Do not use over broken skin or with impaired sensation unless a clinician advises
    • Seek care for sudden severe pain unlike your usual period pattern
    Source notes
    • RCTs and systematic reviews of heat therapy for primary dysmenorrhea
    • Clinical guidance favouring non-drug measures alongside analgesia when appropriate

    Ginger tea

    Grade A — stronger trial support

    Ginger (often 750–2000 mg/day powdered equivalent across study arms) has meta-analytic support for reducing menstrual pain versus placebo, with several trials finding effects in a similar range to NSAIDs.

    Typical use
    Study protocols commonly use standardised ginger powder capsules across the first 1–3 days of menses; a culinary brew is a lighter, self-managed proxy — log dose and timing for your own n-of-1 read.
    Cautions
    • Discuss with a clinician if you take anticoagulants or have gallstones
    • Stop and seek advice if you notice reflux, heartburn or allergic symptoms
    • Not a substitute for prescribed treatment of secondary dysmenorrhea
    Source notes
    • Meta-analyses of ginger for primary dysmenorrhea vs placebo / NSAIDs
    • Trial literature on powdered ginger dosing across early menses days

    Gentle stretching

    Grade B — some clinical support

    Low-intensity exercise and stretching programmes show moderate evidence for easing menstrual pain and improving wellbeing versus usual care, though protocols vary widely.

    Typical use
    5–20 minutes of supported poses or light movement on pain days; consistency across cycles matters more than intensity.
    Cautions
    • Skip positions that worsen pain, dizziness or heavy flooding
    • Modify or rest if you have acute injury or clinician-advised activity limits
    Source notes
    • Reviews of exercise and yoga-style interventions for dysmenorrhea
    • Trials of stretching programmes during menstruation

    Early night

    Grade B — some clinical support

    Short or fragmented sleep associates with higher next-day pain sensitivity; protecting luteal-phase sleep is a practical pain-modulation target even when menstrual-specific RCTs are thinner than for heat or ginger.

    Typical use
    Consistent wind-down 30–60 minutes before a fixed bedtime in the luteal window; quiet hours and reduced late caffeine help many people.
    Cautions
    • Persistent insomnia, loud snoring or gasping warrants clinical sleep assessment
    • Do not use sedating substances without clinician advice
    Source notes
    • Pain-science literature on bidirectional sleep–pain links
    • Wearable and cohort data linking sleep disruption to cycle symptom burden

    Warm bath

    Grade B — some clinical support

    Warmth via baths shares mechanisms with local heat (muscle relaxation, comfort). Direct menstrual-pain RCTs are fewer than for heat packs, so the grade sits below continuous heat protocols.

    Typical use
    Warm (not scalding) bath 10–20 minutes on cramp days; hydrate afterwards.
    Cautions
    • Avoid if dizzy, faint, or advised against hot baths in pregnancy or certain cardiac conditions
    • Keep water comfortably warm to avoid burns or overheating
    Source notes
    • Heat-therapy evidence base for dysmenorrhea (bath as related modality)
    • Clinical self-care guidance for primary period pain

    Breathing exercise

    Grade C — emerging / traditional

    Slow breathing and related autonomic down-regulation can reduce perceived stress and pain intensity for some people; menstrual-specific trial evidence is limited compared with heat or ginger.

    Typical use
    5–10 minutes of paced breathing (for example longer exhales) at onset of cramps or bedtime.
    Cautions
    • Stop if you feel light-headed; return to normal breathing
    • Not a crisis intervention for severe pain or distress
    Source notes
    • Broader evidence for paced breathing in stress and pain modulation
    • Limited condition-specific RCTs for dysmenorrhea

    Magnesium

    Grade B — some clinical support

    Magnesium supplementation has mixed-to-supportive evidence for menstrual pain and PMS symptoms; formulations and doses vary, so personal logging matters.

    Typical use
    Study doses often fall around 200–400 mg elemental magnesium daily in luteal or menstrual windows — confirm form and suitability with a clinician or pharmacist.
    Cautions
    • Kidney disease or medication interactions need clinician review first
    • High doses can cause diarrhoea; stop and seek advice if severe
    Source notes
    • Reviews of magnesium for dysmenorrhea and PMS
    • Heterogeneous trial dosing — treat app logs as personal experiments, not prescriptions

    Pain relief medication

    Grade A — stronger trial support

    NSAID analgesics (for example ibuprofen, naproxen) have strong evidence for primary dysmenorrhea when used appropriately; timing before peak pain often improves control.

    Typical use
    Follow the product label or your clinician’s dose; many people do better starting at the first twinge rather than waiting for peak pain.
    Cautions
    • Ulcers, kidney disease, asthma sensitivity, pregnancy, or anticoagulant use — check with a clinician
    • Do not exceed labelled maximum doses
    Source notes
    • Guideline-level evidence for NSAIDs in primary dysmenorrhea
    • Comparative trials of NSAIDs vs placebo and vs some non-drug measures

    My Evidence (n-of-1)

    Population evidence tells you what often works. My Evidence ranks remedies from your care logs — with confidence and sample-size gates so thin data does not look like proof. Optional dose and timing chips help you and a clinician see what you actually tried. Rankings appear on Insights and can export into the clinician report.

    Prediction honesty

    Pain forecasts show a data-basis band (how much history we have). Verified accuracy appears only after predicted-versus-actual calibration — we do not invent percentage accuracy for marketing.

    Clinical adjacency pathways

    • Heavy bleeding / endo signals: screening → PBAC-style volume → iron context → clinician pack.
    • PMDD pathway: DRSP-style luteal diary, care-plan branch in the luteal window, and a clipboard summary for appointments — educational pattern tracking, not a DSM diagnosis.
    • Perimenopause: STRAW+10-informed cycle staging plus vasomotor/mood severity logs in the clinician report — a staging aid, not a menopause diagnosis.

    Advisory review

    Emmenia does not currently list named clinical advisors on this page. We are assembling an advisory process for evidence grades and pathway copy; until that is live, grades remain product-team syntheses of published literature with the caveats above. We will not invent credentials or affiliations.

    Research participation

    Privacy settings include an opt-in interest / waitlist preference for a future dysmenorrhea outcomes study. A formal study (with IRB oversight) is not launched yet — flipping the toggle does not enrol you or share data today. When a study opens, separate explicit consent will be required.

    Questions

    For data rights and controller details, see the Privacy Policy. For product access tiers, see Pricing.